An Application of an Initial Full Value of Vaccine Assessment Methodology to Measles-Rubella MAPs for Use in Low- and Middle-Income Countries.
Ko M, Frivold C, Mvundura M, Soble A, Gregory C, Christiansen H, Hasso-Agopsowicz M, Fu H, Jit M, Hsu S, Mistilis JJ, Scarna T, Earle K, Menozzi-Arnaud M, Giersing B, Jarrahian C, Yakubu A, Malvolti S, Amorij JP.
Ko M, et al. Among authors: gregory c.
Vaccines (Basel). 2024 Sep 19;12(9):1075. doi: 10.3390/vaccines12091075.
Vaccines (Basel). 2024.
PMID: 39340105
Free PMC article.